Brief: Immutep Ltd Says FDA Granted Orphan Drug Designation For Eftilagimod alfa In Soft Tissue Sarcoma
15/04/2026 02:21
April 15 (Reuters) - Immutep Ltd IMM.AX: IMMUTEP LTD - FDA GRANTS ORPHAN DRUG DESIGNATION FOR EFTILAGIMOD ALFA IN SOFT TISSUE SARCOMA Source text: ID:nASX4fL5nr Further company coverage: IMM.AX